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Objective: Women with endometriosis often need in vitro fertilization (IVF) to conceive. There are con-
ﬂicting data on the results of IVF in patients with endometriosis. The present study was undertaken to
investigate whether or not the stage of endometriosis affects the IVF outcome in order to give the best
patient counseling
Materials and methods: We compared IVF outcome measures between 40 patients with surgically
conﬁrmed minimal and mild endometriosis (American Society for Reproductive Medicine Stage I/II) and
38 patients with moderate and severe endometriosis (Stage III/IV). Each group was also compared with a
control group of 157 patients with tubal factor infertility. Outcome measures included number of folli-
cles, number of oocytes, mean number of ampoules of gonadotropins, cumulative pregnancy, and live
birth rates
Results: Higher cancelation rates, higher total gonadotropin requirements, and lower oocyte yield were
found in women with endometriosis Stage III and IV compared with both the Stage I/II and control
groups. The fertilization rate was higher in Stage III/IV endometriosis compared to Stage I/II. Clinical
pregnancy and live birth rates were comparable between patients with endometriosis Stage I/II and
control group, whereas they were signiﬁcantly lower in patients with endometriosis Stage III/IV
compared to other two groups.
Conclusion: The American Society for Reproductive Medicine classiﬁcation of endometriosis is useful in
predicting IVF outcome. Advanced endometriosis means aworse prognosis for IVF treatment compared to
milder stages or tubal factor infertility. Thedecreased fertilization rate in Stage I/II endometriosismight be a
cause of subfertility in these women, as a result of a hostile environment caused by the disease.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Endometriosis is one of the most puzzling gynecologic diseases.
It affects 2e10% of women in general population and 20e50% of
womenwho are investigated for infertility [1]. This high prevalence
of endometriosis in infertile women has led to the assumption that
there might be a causal relation between endometriosis and
infertility. Despite extensive studies, the exact mechanism by
which endometriosis causes infertility is not clearly understood.
According to European Society of Human Reproduction and
Embryology guidelines, in vitro fertilization and embryo transfer
(IVF-ET) is an appropriate treatment in cases of infertility with a
history of endometriosis. Using IVF-ET, it is possible to bypass the
suspected disturbed functions that are affected in natural cycles byObstetrics, Clinical Center of
Pop-Trajkovic).
bstetrics & Gynecology. Publishedendometriosis, such as altered folliculogenesis, ovulatory
dysfunction, oocyte maturation, cleavage of embryo, and implan-
tation [2,3].
Whether the results of IVF-ET are as good in women with
endometriosis as in patients with other causes of infertility is a
matter for discussion. The results of different studies are contro-
versial. Some investigators have reported poor IVF outcome in
womenwith endometriosis-related infertility [4,5], whereas others
reported high success rates comparable to those in women with
tubal factor infertility [6,7]. Furthermore, some studies reported
that women with advanced stage endometriosis and previous
surgery responded less well to gonadotropin stimulation and had
lower fertilization rates but the effect of different stages of endo-
metriosis on IVF-ET outcome remains unclear [8].
The present study was undertaken to investigate whether or not
the stage of endometriosis affects the IVF outcome in order to give
the best patient counseling.by Elsevier Taiwan LLC. All rights reserved.
Table 1
Patient characteristics and controlled ovarian hyperstimulation parameters. Data are expressed as mean ± standard deviation where appropriate.
Endometriosis I/II (A) Endometriosis III/IV (B) Tubal factor (C) A vs. C B vs. C A vs. B
No. of patients 40 38 157
Age, y 34.7 ± 4.3 30.8 ± 4.8 33.2 ± 3.2 NS <0.01 <0.01
BMI, kg/m2 25.4 ± 5.2 24.7 ± 4.7 25.7 ± 6.1 NS NS NS
Duration of infertility, y 8.1 ± 3.7 5.8 ± 2.4 7.7 ± 4.3 NS <0.05 <0.05
Basal serum FSH, IU/mL 7 ± 2.9 6.1 ± 2.8 7.6 ± 2.9 NS <0.05 NS
Mean no. of ampoules of gonadotropin 33.7 ± 11.2 37.5 ± 16.2 27.2 ± 9.5 <0.05 <0.01 NS
Duration of stimulation, d 8.9 ± 2.1 10.5 ± 3.2 9.22 ± 1.8 NS <0.05 NS
E2 Day 7, pg/mL 722 ± 566 698 ± 423 822 ± 678 <0.05 <0.05 NS
No. of follicles 16 mm 6.9 ± 5.2 4.79 ± 4.5 7.9 ± 6.4 <0.01 <0.005 <0.05
BMI ¼ body mass index; E2 ¼ estradiol; FSH ¼ follicle-stimulating hormone; NS ¼ not signiﬁcant.
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A total of 235 ﬁrst-attempt IVF cycles performed in two IVF units
were prospectively analyzed. Of these, 78 patients were diagnosed
with endometriosis, and all had previously undergone laparoscopy.
Forty patients were diagnosed with minimal and mild endometri-
osis [American Society for Reproductive Medicine (ASRM) Stage I/
II] and 38 withmoderate and severe endometriosis (ASRM Stage III/
IV). Sixty-eight patients had undergone only one, and 12more than
one surgical procedure. In all patients with ovarian endometriosis
the stripping technique was used to excide endometriomas (the
endometrioma was drained with aspiration and the pseudocapsule
was dissected by gentle traction and countertraction using two 5-
mm grasping forceps) and the diagnosis was conﬁrmed histologi-
cally. All patients with endometriosis were treated with three to six
cycles of gonadotropin-releasing hormone (GnRH) analogues after
laparoscopy and prior to IVF. The control group consisted of 157
women who underwent IVF treatment during the same time
period, with laparoscopically diagnosed tubal factor infertility and
without any evidence of endometriosis. The comparison was made
separately between the group of patients with endometriosis Stage
I/II and the control group and patients with endometriosis Stage III/
IV and the control group. Results were also compared between
patients with Stage I/II and Stage III/IV endometriosis.
Depending on the women's age, the antral follicle count and the
basal (Day 3) follicle-stimulating hormone (FSH) concentration, the
long GnRH-agonist downregulation protocol [triptorelin embonate
(Dipherelin) 0.1 mg; Ipsen Pharma Biotech, Paris, France], the short
GnRH-agonist or GnRH antagonist protocol (Cetrotide; Serono
Pharma, Geneva, Switzerland) were used. Ovulation stimulations
were conducted with daily subcutaneous injections of individual
starting doses of recombinant FSH (Folitropin a-Gonal F; Serono
Pharma; or Folitropin b; Puregon; Organon, Oss, The Netherlands)
or human menopausal gonadotropin (Menopur, Feriing, Germany)
at appropriate doses (50e450 IU). Ovarian response to gonado-
tropins was monitored by transvaginal ultrasound and serum
estradiol (E2) measurement every second day from Day 7. Ovula-
tion was triggered by injecting 10,000 IU human chorionic
gonadotropin (hCG) when the leading follicle reached 18 mmwith
appropriate serum E2 levels. Thirty-six hours after administration
of hCG transvaginal ultrasound-guided oocyte aspiration was per-
formed under local anesthesia. After cultivation, ET was performed
3e5 days after oocytes aspiration. All patients received luteal phase
support for 2 weeks. Clinical pregnancy was deﬁned as the visu-
alization of gestational sac at ultrasound examination and
biochemical pregnancy was deﬁned as detection of b-HCG levels in
serum but no signs of pregnancy by ultrasound.
Data are expressed as the mean ± standard deviation or as
percentages when required. Statistical comparisons among groups
were performed using the Fisher exact test, c2 test, Wilcoxon's test,
or Student t test as appropriate. Signiﬁcance was deﬁned as a p
value <0.05.Results
Patient characteristics and ovarian stimulation parameters are
shown in Table 1. Patients with Stage III and IV endometriosis had
lower basal serum FSH levels and required longer stimulation
compared with the control group, whereas all patients with
endometriosis (unrelated to the stage of disease) required more
ampoules of gonadotropins, and attained lower serum E2 levels on
Day 7 and fewer of follicles 16 mm on the day of hCG adminis-
tration compared with the control group. Moreover, the number of
follicles16mmon the day of hCG administrationwas signiﬁcantly
lower in patients with Stage III and IV endometriosis compared
with those with endometriosis Stage I and II. Finally, patients with
endometriosis Stage III and IV were younger and had a shorter
duration of infertility compared with other two groups of patients.
IVF laboratory parameters and IVF outcomes are presented in
Table 2. Patients with endometriosis Stage III and IV had signiﬁ-
cantly higher cycle cancellation rates and higher fertilization rates
but fewer retrieved oocytes, fewer total number of embryos, and
lower implantation rates compared with the other two groups of
patients. Clinical pregnancy rates, multifetal pregnancy rates, and
live birth rates were comparable between patients with endome-
triosis Stage I and II and control group, whereas all those parame-
ters were signiﬁcantly lower in patients with endometriosis Stage
III and IV compared with the other two groups of patients.
The bodymass index andmiscarriage rate showed no signiﬁcant
differences between groups.
Discussion
According to our data, severe endometriosis has a negative in-
ﬂuence on IVF outcome. With increasing severity of endometriosis,
a poorer success rate for IVF was observed. Almost all aspects of IVF
are negatively inﬂuenced by moderate and severe endometriosis,
from ovarian reserve and ovarian response during gonadotropin
stimulation to implantation and pregnancy rate. The only exception
was the fertilization rate.
Analyzing the patient characteristics, we can see that patients
with advanced stages of endometriosis were younger and had a
shorter duration of infertility when beginning IVF. This can simply
be explained by the fact that patients with severe endometriosis
have other symptoms beside infertility (dysmenorrhea, dyspar-
eunia, chronic pelvic pain) when they visit the gynecologist who
refers them to laparoscopy and IVF.
The negative association between advanced endometriosis and
ovarian reserve, ovarian response during stimulation and cancel-
lation rate might be ascribed to the effect of previous surgical
treatment and to endometriosis as a disease itself. Studies sup-
porting the theory of surgery-mediated damage showed removal of
healthy tissue by laparoscopic stripping and surgery related local
inﬂammation or vascular compromise following electrosurgical
coagulation [8,9]. By contrast, using pathological sections of the
Table 2
In vitro fertilization laboratory parameters and outcome in women with different stages of endometriosis and women with tubal factor infertility. Data are expressed as
mean ± standard deviation when appropriate.
Endometriosis I/II (A) Endometriosis III/IV (B) Tubal factor (C) A vs. C B vs. C A vs. B
Cycle cancellation rate, % 12.7 20.8 5.7 <0.01 <0.005 <0.05
No. of oocytes retrieved 5.9 3.6 ± 3.4 7.6 ± 6.1 <0.01 <0.001 <0.05
Fertilization rate, % 49.5 59.8 54.2 NS <0.01 NS
Mean no. of embryos 3 ± 1.9 1.9 ± 1.6 4 ± 2.8 <0.05 <0.001 <0.01
Implantation rate, % 25.7 17.6 23.11 NS <0.05 <0.05
Cumulative pregnancy rate per ET, % 43.2 31.03 46.9 NS <0.001 <0.05
Miscarriages, % 23.5 23.8 19.8 NS NS NS
Multifetal pregnancies, % 41.5 27.5 40 NS <0.01 <0.01
Live birth rate per ET, % 28.8 20.7 27.5 NS <0.05 <0.05
ET ¼ embryo transfer.
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reduced follicular numbers and activity antecedent to surgery.
Whether ovarian damage precedes or follows surgery remains
controversial [10]. Elucidation of this point is of utmost interest
since it would strongly impact on the decision of whether to
operate on women with advance stages of endometriosis who are
selected for IVF.
The fertilization rate in women with severe endometriosis was
higher than in those with minimal and mild endometriosis and
similar to patients with tubal factor infertility. One possible
explanation for this may be that lesions associated with severe
endometriosis are burned out lesions, resulting in pelvic adhesions
rather than lesions with active endometrial glands. Thus it may be
the secretory components of an active lesion that affect oocyte
quality and thus fertilization, which is the case in milder endo-
metriosis. This supports results of previous studies showing an
increase in chemotactic activity in the peritoneal ﬂuid of women
with active endometriosis lesions [11e13].
Patients with advanced stages of endometriosis had lower
pregnancy and live birth rate compared to control group and pa-
tients with minimal and mild endometriosis. Arici and al showed a
60% pregnancy rate per ET in women with Stage I and II of endo-
metriosis and only 7% inwomenwith endometriosis Stage III and IV
[14]. Azem et al and three more studies also presented signiﬁcantly
lower pregnancy and live birth rate in patients with Stage III and IV
endometriosis [15e18]. Nevertheless it is important to notice that a
21% live birth rate is still a good percentage and probably is the best
chance for patients with advanced endometriosis to conceive, given
that according to ASRM their monthly pregnancy rate during nat-
ural cycling is <2% [19]. Regarding the fact that patients with
advanced endometriosis have lower pregnancy and multifetal
rates, it can be concluded that fertilization rates are not impaired.
Endometrial receptivity is negatively affected in these patients.
More studies are needed to support this theory.
Our data have several clinical implications. First, they suggest
that IVF outcome is inﬂuenced by different stages of endometriosis
through different mechanisms. Moderate and severe endometri-
osis have detrimental effects on ovarian response during stimu-
lation, cycle cancellation rate and implantation rate. Minimal and
mild endometriosis impair the fertilization rate due to the occur-
rence of lesions with active endometrial glands. The ASRM clas-
siﬁcation has proved to be useful in predicting the IVF outcome
and might be used for planning the procedure and counseling
patients.
The ASRM classiﬁcation of endometriosis is useful in predicting
the IVF outcome. Stage III and IV endometriosis means a worse
prognosis for IVF treatment compared to milder stages or tubal
factor infertility. A decreased fertilization rate in Stage IeII endo-
metriosis might be a cause of subfertility in these women, as a
result of a hostile environment caused by the disease.Conﬂicts of interest
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